Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

Beypinar, IsmailAraz, Murat2026-01-242026-01-2420230028-47931533-4406https://doi.org/10.1056/NEJMc2306786https://hdl.handle.net/20.500.12868/5838[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessCabozantinib plus Nivolumab and Ipilimumab in Renal-Cell CarcinomaLetter10.1056/NEJMc23067863895476478375308322-s2.0-85166143198Q1WOS:001086308700018Q1